跳至主要内容
临床试验/EUCTR2019-000668-27-ES
EUCTR2019-000668-27-ES进行中(未招募)1 期

Pilot Project for the Treatment of Perianal Disease through the Local Injection of Remsima Guided by Ultrasound. Number of cases.

Marta Maia Boscá Watts0 个研究点目标入组 10 人开始时间: 2019年7月4日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -Patients diagnosed with Crohn's disease with complex PD.
  • -Older than 18 years-old.
  • -EPA with no response, or partial response at the discretion of the clinician, to usual medical treatment and / or drainage of abscesses, treatment of fistulas and / or placement of perianal setons.
  • -PD with less than two internal holes and three external holes.
  • -PDAI> 4.
  • - Absence of rectal involvement or mild endoscopic activity (SES-CD <5).
  • - Willing to enter the study and sign the informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Patients with PD not associated with IBD.
  • -Patients with moderate or severe allergic reactions due to anti-TNF.
  • -PD with more than two internal holes or three external holes.
  • -Rectovaginal fistulas.
  • -Moderate or severe proctitis.
  • -Anal or rectal stenosis that prevents an endoscopic ultrasound.
  • -Patients with more than two fistulous trajectories.
  • -Patients with perianal abscesses not drained of more than 2 cm.
  • -PDAI <4.
  • -Patients receiving specific local treatments for perianal disease such as stem cell injection. It must have been more than a year since the patient was treated with stem cells to be included in this study.
  • -Definitive ileostomy carrier.
  • -Pregnancy or breastfeeding, or desire for it during next year.
  • -Recent surgical treatment with advancement sleeve flaps or others that were not drainage and / or seton placement.
  • -Any other condition that in the opinion of the investigator prevents the patient from completing the study.
  • -Any other condition that reduces the life expectancy to less than 1 year, including knowledge of cancer.
  • -Patients who do not accept their participation in the study and / or do not sign the informed consent document.

研究者

发起方
Marta Maia Boscá Watts

相似试验